Condon J, Gosden C, Gardener D, Nickson P, Hewison M, Howie A J, Stewart P M
Department of Medicine, University of Birmingham, Queen Elizabeth Hospital, United Kingdom.
J Clin Endocrinol Metab. 1998 Dec;83(12):4490-7. doi: 10.1210/jcem.83.12.5302.
In adult life, the type 2 isozyme of 11beta-hydroxysteroid dehydrogenase (11betaHSD2) protects the mineralocorticoid receptor (MR) from glucocorticoid by inactivating cortisol to cortisone. 11betaHSD2 activity has been reported in human fetal tissues, where glucocorticoids may impair fetal growth yet are also required for normal fetal development. Using digoxigenin-labeled complementary ribonucleic acid (RNA) probes and an in-house 11betaHSD2 antiserum, we have analyzed the expression of 11betaHSD2, MR, and glucocorticoid receptor (GR) in human fetal tissues of gestational age 6-17 weeks (n=15). 11BetaHSD2 expression was absent at gestational age 6+ weeks, but was expressed in abundance in many fetal tissues between 8-12 weeks. At this time, 11betaHSD2 colocalized with GR messenger RNA (mRNA) expression in metanephros, gut, muscle, spinal cord and dorsal root ganglia, periderm, sex chords of testis, and adrenal. In particular within fetal kidney, intense expression of 11betaHSD2 and GR mRNA was observed over Bowman's capsule and the vascular tufts of developing glomeruli as they migrated from the surface of the kidney to the inner cortex. Only lung and adrenal medullary rests demonstrated high levels of GR mRNA but low levels of 11betaHSD2. 11BetaHSD2 mRNA and immunoreactivity staining patterns were similar, with the exception of the fetal adrenal, where mRNA was localized to the outer definitive zone but immunoreactivity was localized to the inner fetal zone. Colocalization of 11betaHSD2 (and GR mRNA) with MR mRNA was observed principally within epithelial cells of collecting ducts, particularly after 16 weeks gestation when the pattern of distribution of 11betaHSD2 became more adult in nature. High levels of MR mRNA were observed within developing bone. The data indicate that 11betaHSD2 in fetal life principally modulates ligand access to the GR in most fetal tissues, notably glomeruli and tubules in the developing kidney, testis, and periderm, and this may be have ramifications for fetal sodium homeostasis and differentiation. The development of tissues previously shown to have a critical requirement for glucocorticoids, such as lung and adrenal medulla, is facilitated by the expression of GR mRNA, but not 11betaHSD2. The expression of MR mRNA in high abundance in bone suggests a role for corticosteroids in human bone development, and the low/absent expression of 11betaHSD2 at this site suggests that it is functionally acting as a GR.
在成年期,11β-羟类固醇脱氢酶2型(11βHSD2)同工酶通过将皮质醇转化为可的松,保护盐皮质激素受体(MR)免受糖皮质激素的影响。已有报道称人类胎儿组织中存在11βHSD2活性,在胎儿组织中糖皮质激素可能会损害胎儿生长,但正常胎儿发育也需要糖皮质激素。我们使用地高辛标记的互补核糖核酸(RNA)探针和自制的11βHSD2抗血清,分析了孕龄6 - 17周的人类胎儿组织(n = 15)中11βHSD2、MR和糖皮质激素受体(GR)的表达情况。在孕6 +周时未检测到11βHSD2表达,但在8 - 12周时,许多胎儿组织中大量表达。此时,11βHSD2与GR信使核糖核酸(mRNA)在肾元、肠道、肌肉、脊髓和背根神经节、周皮、睾丸性索和肾上腺中共同表达。特别是在胎儿肾脏中,随着发育中的肾小球从肾脏表面迁移到内皮质,在鲍曼囊和肾小球血管襻上观察到11βHSD2和GR mRNA的强烈表达。只有肺和肾上腺髓质残余物显示出高水平的GR mRNA但低水平的11βHSD2。11βHSD2 mRNA和免疫反应性染色模式相似,但胎儿肾上腺除外,其mRNA定位于外层确定带,而免疫反应性定位于内层胎儿带。11βHSD2(和GR mRNA)与MR mRNA的共同表达主要在集合管的上皮细胞中观察到,特别是在妊娠16周后,此时11βHSD2的分布模式更接近成人。在发育中的骨骼中观察到高水平的MR mRNA。数据表明,胎儿期的11βHSD2主要调节大多数胎儿组织中配体与GR的结合,特别是在发育中的肾脏、睾丸和周皮的肾小球和肾小管中,这可能对胎儿钠稳态和分化产生影响。先前已证明对糖皮质激素有关键需求的组织,如肺和肾上腺髓质,其发育受到GR mRNA表达的促进,但不受11βHSD2表达的促进。骨骼中高丰度的MR mRNA表达表明皮质类固醇在人类骨骼发育中起作用,而该部位11βHSD2的低表达/无表达表明它在功能上作为GR起作用。